North Carolina

Startup scores $6M to give metastasizing cancer patients 'options'

Wednesday, August 22, 2018

By Lauren K. Ohnesorge

Armed with $6 million, a Durham pharma startup is trying to save lives – and a just-released securities filing only tells part of the story.

That’s according to Cereius CEO Ed Field, speaking Wednesday after a securities disclosure shows more than $1 million of the $6 million round has closed, with infusions from three investors so far.

To read the full article, please go to Triangle Business Journal.